Threshold Pharma (THLD) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	15.16M
Marketable securities
Prepaid expenses and other current assets	1.02M
Total current assets	29.53M
Property and equipment, net	159K
Restricted cash and other assets	0
Total assets	29.69M
Accounts payable	699K
Accrued clinical and development expenses
Accrued liabilities	1.11M
Total current liabilities	3.72M
Warrant liability
Deferred rent	63K
Total liabilities	6.77M
Commitments and contingencies (Note 6)	0
Preferred stock, $0.001 par value, 2,000,000 shares authorized; no shares issued and outstanding	0
Common stock, $0.001 par value, shares authorized: 150,000,000 shares; issued and outstanding: 48,805,008 shares at June 30, 2011 and 33,702,242 shares at December 31, 2010	72K
Additional paid-in capital	372.7M
Accumulated other comprehensive gain (loss)	2K
Deficit accumulated during the development stage	-349.85M
Total stockholders' equity	22.92M
Total liabilities and stockholders' equity	29.69M

Entities mentioned with THLD

View All Entities